| Literature DB >> 25708933 |
Franklin L Nobrega1, Ana Rita Costa1, Leon D Kluskens1, Joana Azeredo2.
Abstract
The success of phage therapy is dependent on the development of strategies able to overcome the limitations of bacteriophages as therapeutic agents, the creation of an adequate regulatory framework, the implementation of safety protocols, and acceptance by the general public. Many approaches have been proposed to circumvent phages' intrinsic limitations but none have proved to be completely satisfactory. In this review we present the major hurdles of phage therapy and the solutions proposed to circumvent them. A thorough discussion of the advantages and drawbacks of these solutions is provided and special attention is given to the genetic modification of phages as an achievable strategy to shape bacteriophages to exhibit desirable biological properties.Keywords: bacteriophages; genetic modification; phage therapy; recombineering
Mesh:
Year: 2015 PMID: 25708933 DOI: 10.1016/j.tim.2015.01.006
Source DB: PubMed Journal: Trends Microbiol ISSN: 0966-842X Impact factor: 17.079